首站-论文投稿智能助手
典型文献
Qi-Tai-Suan,an oleanolic acid derivative,ameliorates ischemic heart failure via suppression of cardiac apoptosis,inflammation and fibrosis
文献摘要:
Although anti-thrombotic therapy has been successful for prevention of deaths from acute myocardial infarction(MI),by far,there are few preventive and therapeutic options for ischemic heart failure(IHF)after MI.Qi-Tai-Suan(QTS)is an oleanolic acid(OA)derivative which once underwent a clinical trial for treating hepatitis.In this study,we investigated the potential cardiopro-tective effect of QTS on IHF.IHF mouse model was constructed by coronary artery ligation in male C57BL/6J mice,and the protect-ive effects of QTS on IHF were examined by echocardiography measurement,histological and TUNEL analysis,etc.We found that QTS exhibited promising cardioprotective effect on IHF.QTS treatment significantly improved cardiac function of IHF mice and the symptoms of heart failure.Notably,QTS had much better oral bioavailability(F=41.91%)in mice than its parent drug OA,and took effects mainly as its original form.Mechanistically,QTS ameliorated ischemic heart failure likely through suppression of cardiac apop-tosis,inflammation and fibrosis.Taken together,QTS holds great promise as a preventive and therapeutic agent for ischemic heart fail-ure and related diseases.
文献关键词:
作者姓名:
QIAN Ming;FENG Zhi-Qi;ZHENG Ru-Nan;HU Kai-Wen;SUN Jia-Ze;SUN Hong-Bin;DAI Liang
作者机构:
Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease,State Key Laboratory of Natural Medicines,China Pharma-ceutical University,Nanjing 210009,China
文献出处:
引用格式:
[1]QIAN Ming;FENG Zhi-Qi;ZHENG Ru-Nan;HU Kai-Wen;SUN Jia-Ze;SUN Hong-Bin;DAI Liang-.Qi-Tai-Suan,an oleanolic acid derivative,ameliorates ischemic heart failure via suppression of cardiac apoptosis,inflammation and fibrosis)[J].中国天然药物,2022(06):432-442
A类:
Suan,QTS,cardiopro,apop
B类:
Qi,Tai,oleanolic,acid,derivative,ameliorates,ischemic,heart,failure,via,suppression,cardiac,apoptosis,inflammation,fibrosis,Although,anti,thrombotic,therapy,has,been,successful,prevention,deaths,from,acute,myocardial,infarction,MI,by,there,few,preventive,therapeutic,options,IHF,after,OA,which,once,underwent,clinical,trial,treating,hepatitis,In,this,study,investigated,potential,mouse,model,was,constructed,coronary,artery,ligation,male,C57BL,6J,mice,effects,were,examined,echocardiography,measurement,histological,TUNEL,analysis,etc,We,found,that,exhibited,promising,cardioprotective,treatment,significantly,improved,function,symptoms,Notably,had,much,better,oral,bioavailability,than,its,parent,drug,took,mainly,original,form,Mechanistically,ameliorated,likely,through,Taken,together,holds,great,promise,agent,related,diseases
AB值:
0.53491
相似文献
Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway
Xu-xia Li;Peng Zhang;Yang Yang;Jing-jing Wang;Yan-jun Zheng;Ji-liang Tan;Shen-yan Liu;Yong-ming Yan;You-yi Zhang;Yong-xian Cheng;Huang-tian Yang-CAS Key Laboratory of Tissue Microenvironment and Tumor,Laboratory of Molecular Cardiology,Shanghai Institute of Nutrition and Health,University of Chinese Academy of Sciences,CAS,Shanghai 200031,China;State Key Laboratory of Phytochemistry and Plant Resources in West China,Kunming Institute of Botany,CAS,Kunming 650201,China;Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital;NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides;Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China;School of Pharmaceutical Sciences,Health Science Center,Shenzhen University,Shenzhen 518060,China;Department of Cardiology,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Shanghai 200233,China;Institute for Stem Cell and Regeneration,CAS,Beijing 100101,China
Kanglexin delays heart aging by promoting mitophagy
Hui-min Li;Xin Liu;Zi-yu Meng;Lei Wang;Li-min Zhao;Hui Chen;Zhi-xia Wang;Hao Cui;Xue-qing Tang;Xiao-han Li;Wei-na Han;Xue Bai;Yuan Lin;Heng Liu;Yong Zhang;Bao-feng Yang-Department of Pharmacology(the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China;Department of Medicinal Chemistry and Natural Medicine Chemistry,College of Pharmacy,Harbin Medical University,Harbin 150081,China;Research Unit of Noninfectious Chronic Diseases in Frigid Zone,Chinese Academy of Medical Sciences,Harbin 150086,China;Institute of Metabolic Disease,Heilongjiang Academy of Medical Science,Harbin 150086,China;Department of Pharmacology and Therapeutics,Melbourne School of Biomedical Sciences,Faculty of Medicine,Dentistry and Health Sciences University of Melbourne,Melbourne,Australia
Asiatic acid alleviates ischemic myocardial injury in mice by modulating mitophagy-and glycophagy-based energy metabolism
Fan Qiu;Yi Yuan;Wei Luo;Yan-shan Gong;Zhong-ming Zhang;Zhong-min Liu;Ling Gao-Translational Medical Center for Stem Cell Therapy&Institute for Regenerative Medicine,Shanghai East Hospital,Tongji University School of Medicine,Shanghai 200123,China;Department of Cardiovascular and Thoracic Surgery,Shanghai East Hospital,Tongji University School of Medicine,Shanghai 200120,China;Department of Cardiovascular and Thoracic Surgery,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221006,China;Shanghai Institute of Stem Cell Research and Clinical translation,Shanghai East Hospital,Tongji University,Shanghai 200120,China;Shanghai Engineering Research Center for Stem Cell Clinical Treatment,Shanghai 200123,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis
Ying Dong;Bi-xi Tang;Qi Wang;Li-wei Zhou;Cong Li;Xuan Zhang;Dan-dan Sun;Xin Sun;Xue-mei Zhang;Bing Xiong;Jia Li;Hong Shi;Dan-qi Chen;Yi Zang-State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Pharmacology,School of Pharmacy,Fudan University,Shanghai 201203,China;Department of Medicinal Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Center for Supramolecular Chemistry and Catalysis and Department of Chemistry,College of Sciences,Shanghai University,Shanghai 200444,China;Schoolof Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210023,China;Schoolof Pharmacy,Henan University,Kaifeng 475004,China;Open Studio for Druggability Research of Marine Natural Products,Pilot National Laboratory for Marine Science and Technology(Qingdao),Qingdao 266237,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,UCAS,Hangzhou 310024,China;Department of Anesthesiology of Shanghai Pulmonary Hospital,School of medicine,Tongji University,Shanghai 200433,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
Therapeutic potential of colchicine in cardiovascular medicine:a pharmacological review
Fan-shun Zhang;Qing-ze He;Chengxue Helena Qin;Peter J.Little;Jian-ping Weng;Suo-wen Xu-Institute of Endocrine and Metabolic Diseases,The First Affiliated Hospital of USTC,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230001,China;Faculty of Pharmacy and Pharmaceutical Sciences,Monash Institute of Pharmaceutical Sciences,Monash University(Parkville Campus),381 Royal Parade,Parkville 3052 VIC,Australia;Sunshine Coast Health Institute,University of the Sunshine Coast,Birtinya 4575 QLD,Australia;School of Pharmacy,The University of Queensland,Woolloongabba 4102 QLD,Australia;Biomedical Sciences and Health Laboratory of Anhui Province,University of Science&Technology of China,Hefei 230027,China
Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis
Tian-yu Li;Wei Su;Liang-liang Li;Xiao-guang Zhao;Na Yang;Jia-xin Gai;Xin Lv;Jing Zhang;Meng-qin Huang;Qing Zhang;Wei-hang Ji;Xiao-ying Song;Yu-hong Zhou;Xue-lian Li;Hong-li Shan;Hai-hai Liang-Department of Pharmacology(State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China;Zhuhai People's Hospital,Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment,Zhuhai Hospital Affiliated with Jinan University,Jinan University,Zhuhai 519000,China;Department of Cardiology,The Fourth Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA,Institute for Frontier Medical Technology,Shanghai University of Engineering Science,Shanghai 201620,China;Research Unit of Noninfectious Chronic Diseases in Frigid Zone(2019RU070),Chinese Academy of Medical Sciences,Harbin 150081,China
Sustained over-expression of calpain-2 induces age-dependent dilated cardiomyopathy in mice through aberrant autophagy
Xiao-yun Ji;Dong Zheng;Rui Ni;Jin-xi Wang;Jian-qiang Shao;Zer Vue;Antentor Hinton Jr.;Long-Sheng Song;Guo-Chang Fan;Subrata Chakrabarti;Zhao-liang Su;Tian-qing Peng-International Genome Center,Jiangsu University,Zhenjiang 212013,China;Lawson Health Research Institute,London Health Sciences Centre,London,ON N6A 5W9,Canada;Department of Pathology and Laboratory Medicine,Western University,London,ON N6A 5C1,Canada;Centre of Clinical Laboratory,the First Affiliated Hospital of Soochow University,Suzhou 215006,China;Division of Cardiovascular Medicine,Department of Internal Medicine,Abboud Cardiovascular Research Center,Carver College of Medicine,University of Iowa,Iowa City,IA 52242,USA;CentrallMicroscopy Research Facility,University of Iowa,Iowa City,IA 52242,USA;Department of Molecular Physiology and Biophysics,Vanderbilt University,Nashville,TN 37232,USA;Department of Pharmacology and Systems Physiology,University of Cincinnati College of Medicine,Cincinnati,OH 45267,USA;Department of Medicine,Western University,London,ON N6A 5W9,Canada
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。